CYDY
Price:
$0.123
Market Cap:
$150.04M
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as coronavirus disease (COVID-19). It is also conducting a Phase 1b/2 clinical trial with leronlimab in metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.[Read more]
Industry
Biotechnology
IPO Date
2006-12-13
Stock Exchange
PNK
Ticker
CYDY
According to CytoDyn Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 154.04M. This represents a change of -25.98% compared to the average of 208.11M of the last 4 quarters.
The mean historical Enterprise Value of CytoDyn Inc. over the last ten years is 359.35M. The current 154.04M Enterprise Value has changed 4.19% with respect to the historical average. Over the past ten years (40 quarters), CYDY's Enterprise Value was at its highest in in the February 2021 quarter at 2.56B. The Enterprise Value was at its lowest in in the February 2015 quarter at 52.64M.
Average
359.35M
Median
141.17M
Minimum
60.14M
Maximum
1.25B
Discovering the peaks and valleys of CytoDyn Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.02%
Maximum Annual Enterprise Value = 1.25B
Minimum Annual Increase = -78.71%
Minimum Annual Enterprise Value = 60.14M
Year | Enterprise Value | Change |
---|---|---|
2024 | 170.34M | -32.35% |
2023 | 251.79M | -4.16% |
2022 | 262.71M | -78.71% |
2021 | 1.23B | -1.40% |
2020 | 1.25B | 1.02% |
2019 | 112.00M | 33.45% |
2018 | 83.92M | 2.23% |
2017 | 82.09M | -3.14% |
2016 | 84.75M | 40.92% |
2015 | 60.14M | 113.46% |
The current Enterprise Value of CytoDyn Inc. (CYDY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
228.28M
5-year avg
634.12M
10-year avg
359.35M
CytoDyn Inc.’s Enterprise Value is less than Intercept Pharmaceuticals, Inc. (915.81M), less than Madrigal Pharmaceuticals, Inc. (6.99B), less than scPharmaceuticals Inc. (204.48M), less than Akero Therapeutics, Inc. (1.95B), greater than Aravive, Inc. (-3158140.00), greater than Cardiff Oncology, Inc. (150.44M), greater than Reviva Pharmaceuticals Holdings, Inc. (28.64M), greater than eFFECTOR Therapeutics, Inc. (3.64M), greater than PDS Biotechnology Corporation (85.57M), greater than Navidea Biopharmaceuticals, Inc. (-2555017.00),
Company | Enterprise Value | Market cap |
---|---|---|
915.81M | $794.69M | |
6.99B | $7.23B | |
204.48M | $201.62M | |
1.95B | $2.23B | |
-3158140.00 | $2.95M | |
150.44M | $174.10M | |
28.64M | $33.39M | |
3.64M | $1.88K | |
85.57M | $118.93M | |
-2555017.00 | $50.04K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CytoDyn Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CytoDyn Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is CytoDyn Inc.'s Enterprise Value?
What is the highest Enterprise Value for CytoDyn Inc. (CYDY)?
What is the 3-year average Enterprise Value for CytoDyn Inc. (CYDY)?
What is the 5-year average Enterprise Value for CytoDyn Inc. (CYDY)?
How does the current Enterprise Value for CytoDyn Inc. (CYDY) compare to its historical average?